| Literature DB >> 33394948 |
Lara Gloria González García, Silvia Rodríguez Manchón, Daniel Mata Zubillaga, Cristina García Aparicio, Ana Elisa Laso Alonso, Sara Corral Hospital, Mª Cristina Amigo Bello.
Abstract
Entities:
Mesh:
Year: 2021 PMID: 33394948 PMCID: PMC7780935 DOI: 10.1097/PEC.0000000000002308
Source DB: PubMed Journal: Pediatr Emerg Care ISSN: 0749-5161 Impact factor: 1.602
FIGURE 1Patients admitted on the Emergency Department during the state of alarm.
Clinical Characteristics of the Patients During Period 1 (March 15–March 29)
| Year 2020 (March 15–March 29) | Year 2019 (March 15–March 29) | Statistical Significance, | |
|---|---|---|---|
| n | 30 | 142 | |
| Age, median (IQR), y | 29 (13–68) | 39 (21–74) | |
| Age group, n (%) | |||
| <1 y | 6 (20%) | 23 (16.2%) | |
| 1–2 y | 7 (23.3%) | 18 (12.7%) | |
| 2–3 y | 6 (20%) | 22 (15.5%) | |
| 3–6 y | 4 (13.3%) | 42 (29.6%) | |
| 6–14 y | 7 (23.3%) | 37 (26.1%) | |
| Male sex, n (%) | 18 (60%) | 76 (53.5%) | |
| Duration of symptoms, median (IQR), h | 18 (6–44) | 24 (10–48) | |
| Diagnosis, n (%) | |||
| Upper respiratory infections | 8 (26.7%) | 24 (16.9%) | |
| Skin lesions | 4 (13.3%) | 8 (5.6%) | |
| Abdominal pain | 4 (13.3%) | 11 (7.7%) | |
| Febrile syndrome | 3 (10%) | 22 (15.5%) | |
| Traumatic head injuries | 2 (6.7%) | 2 (2.1%) | |
| Pneumonia | 2 (6.7%) | 2 (1.4%) | |
| Acute gastroenteritis | 2 (6.7%) | 33 (23.2%) | |
| Asthma/bronchiolitis | 2 (6.7%) | 11 (7.7%) | |
| Urinary tract infections | 1 (3.3%) | 1 (0.7%) | |
| Streptococcal tonsilitis/otitis media | 1 (3.3%) | 19 (13.4%) | |
| Others | 1 (3.3%) | 8 (5.6%) | |
| COVID-19 in health records, n (%) | |||
| Suspected COVID-19 infection | 12 (40%) | ||
| Confirmed cases COVID-19 (positive PCR) | 0 | ||
| Treatment, n (%) | |||
| Antibiotic prescription | 3 (10%) | 23 (16.4%) | |
| Oral corticosteroids | 0 | 9 (6.4%) | |
| Complementary tests, n (%) | 17 (56.6%) | 42 (29.6%) | 0.005 |
| Chest x-ray | 5 (29.4%) | 6 (6.5%) | 0.013 |
| Blood analysis | 6 (35.3%) | 23 (24.5%) | |
| Urine analysis | 4 (23.5%) | 8 (8.6%) | |
| Ultrasound | 3 (17.6%) | 6 (6.5%) | |
| Oropharyngeal or nasopharyngeal swabs for respiratory virus testing | 7 (41.2%) | 5 (5.4%) | <0.0001 |
| Discharge/follow-up, n (%) | |||
| Hospital admission | 7 (23.3%) | 26 (18.3%) | |
| Return within 15 d | 0 | 10 (15.4%) | |
| Primary care follow-up | 11 (36.7%) | 53 (37.6%) | |
| Telephone follow-up | 10 (90%) | 1 (1.88%) | <0.0001 |
IQR, interquartile range; PCR, polymerase chain reaction.